Astellas Gene Therapies Is A Biotechnology Company Based In San Franciscocaliforniaand A Subsidiary Of Astellas Pharma Incfounded In 2012The Company Employs Around 395 People And Is Dedicated To Developing And Commercializing Gene Therapy Productsastellas Gene Therapies Focuses On Creating Genetic Medicines Aimed At Delivering Significant Benefits To Patientsparticularly Those With Rare Diseases The Company Explores Three Main Gene Therapy Modalitiesgene Replacementexon Skipping Gene Therapyand Vectorized Rna Knockdownthese Approaches Utilize Various Techniquesincluding Gene Transfer And Adeno Associated Virusaavdelivery Methodsastellas Gene Therapies Has A Strong Pipeline Of Products Targeting Conditions Such As X Linked Myotubular Myopathypompe Diseasemuscular Dystrophy In Childrenand Other Neuromuscular Diseases With Facilities In San Franciscosouth San Franciscoand Sanfordnorth Carolinaastellas Gene Therapies Combines Its Internal Manufacturing Capabilities With Expertise In Gene Therapy Development To Advance Its Mission Of Improving Patient Outcomes
